Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Npj Mental Health Research|November 3, 2025
Unexpected events and prosocial behavior: the Batman effectFrancesco Pagnini, Francesca Grosso, Cesare Cavalera, et al.
Human Gene Therapy|April 13, 2019
Constraints on Human CD34+ Cell Fate due to Lentiviral Vectors Can Be Relieved by Valproic AcidAlice Moussy, Nan Papili Gao, Guillaume Corre, et al.
Science Translational Medicine|January 7, 2026
Restoration of progranulin by engineered hematopoietic stem cell-derived microglia corrects phenotypes of granulin knockout miceYuri Ciervo, Pietro Rigoni, Linda Bucciarelli, et al.
Molecular Therapy. Methods & Clinical Development|May 1, 2018
Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined ImmunodeficiencyValentina Poletti, Sabine Charrier, Guillaume Corre, et al.
Molecular Therapy. Methods & Clinical Development|December 12, 2018
Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell DiseaseValentina Poletti, Fabrizia Urbinati, Sabine Charrier, et al.
Human Gene Therapy|September 11, 2018
Gene Therapy for Sickle Cell Disease: A Lentiviral Vector Comparison StudyFabrizia Urbinati, Beatriz Campo Fernandez, Katelyn E Masiuk, et al.
EMBO Molecular Medicine|March 6, 2023
An innovative hematopoietic stem cell gene therapy approach benefits CLN1 disease in the mouse modelMarco Peviani, Sabyasachi Das, Janki Patel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 25, 2008
Correction of laminin-5 deficiency in human epidermal stem cells by transcriptionally targeted lentiviral vectorsFrancesca Di Nunzio, Giulietta Maruggi, Stefano Ferrari, et al.
Molecular Therapy. Nucleic Acids|April 24, 2023
Novel lentiviral vectors for gene therapy of sickle cell disease combining gene addition and gene silencing strategiesMégane Brusson, Anne Chalumeau, Pierre Martinucci, et al.
Pageof 4